Cefazolin and Symbicort drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Symbicort (budesonide; formoterol fumarate dihydrate). Common drug interactions include atrial fibrillation among females and pneumothorax among males.
The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Symbicort. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.
What is Cefazolin?
Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.
What is Symbicort?
Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,792 Symbicort users. Check the latest studies of Symbicort.
56 people who take Cefazolin and Symbicort together, and have interactions are studied.

What are the common drug interactions of Cefazolin and Symbicort, by gender? *:
female:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Bipolar disorder (mood disorder)
- Blindness transient (sudden loss of vision)
- Blood iron decreased
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
- Burning sensation
- Cardiac murmur (an heart sound in valve abnormality)
- Cerebral haemorrhage (bleeding within the brain)
male:
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
- Ascites (accumulation of fluid in the abdominal cavity)
- Generalised oedema (swelling all over the body)
- Renal failure (kidney dysfunction)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Cholangitis chronic (long lasting infection of the bile duct)
- Gamma-glutamyltransferase increased
- Heart rate increased
What are the common drug interactions of Cefazolin and Symbicort, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Cerebral haemorrhage (bleeding within the brain)
- Eye swelling
- Hyperkalaemia (damage to or disease of the kidney)
- Metastases to central nervous system (cancer spreads to central nervous system)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Post procedural complication
- Pulmonary embolism (blockage of the main artery of the lung)
- Rash pruritic (redness with itching)
50-59:
- Quality of life decreased
- Thoracic vertebral fracture
- Upper limb fracture
- Wrist fracture
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Blood creatinine increased
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
60+:
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
- Fall
- Generalised oedema (swelling all over the body)
- Pneumonia
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Upper limb fracture
- Chronic kidney disease
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Hospitalisation
- Ketoacidosis (high concentrations of ketone bodies in blood)
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 26.79%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 16.07%
- High Blood Pressure: 8 people, 14.29%
- Depression: 7 people, 12.50%
- Constipation: 6 people, 10.71%
- Lung Disorder (lung disease): 6 people, 10.71%
- Insomnia (sleeplessness): 6 people, 10.71%
- Pain: 5 people, 8.93%
- Urination - Painful: 4 people, 7.14%
- Back Pain: 4 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Cefazolin and Symbicort?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cefazolin and Symbicort:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefazolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Symbicort:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefazolin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Symbicort and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefazolin sodium and budesonide; formoterol fumarate dihydrate (the active ingredients of Cefazolin and Symbicort, respectively), and Cefazolin and Symbicort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Prilosec and Oxymetazoline Hydrochloride - 3 seconds ago
- How effective is Orsythia for Birth Control? - 3 seconds ago
- Drug interactions of Cimzia and Polaramine - 4 seconds ago
- Drug interactions of Aripiprazole and Rivaroxaban - 6 seconds ago
- Drug interactions of Vitamin B12 and Sotalol Hydrochloride - 7 seconds ago
- Drug interactions of Amlodipine Besylate and Paroxetine Hydrochloride - 18 seconds ago
- Could Desflurane cause Diarrhea Aggravated? - 24 seconds ago
- Renal Cell Carcinoma and Aspartate Aminotransferase Increased - 40 seconds ago
- Gabapentin vs. Carisoprodol, side effect and effectiveness comparison - 42 seconds ago
- Could Prometrium cause Staphylococcal Infection? - 50 seconds ago